Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1509196Generated: October 31, 2026

Diisopropylethylamine → HCID 67256543, compound

https://huagongshe.com/reaction/1509196

Reaction equation

Participants

RoleNameHCIDCharge
ReactantDiisopropylethylamineHCID 81531—
ReactantSodium BicarbonateHCID 516892—
ReactantHCID 67257668HCID 67257668—
ReactantHCID 86683601HCID 86683601—
SolventTetrahydrofuranHCID 8028—
ProductHCID 67256543HCID 67256543—
ProductHCID 67257090HCID 67257090—

Reaction Steps

In a 100 mL round bottom flask was added tert-butyl 1-(4-(5-amino-6-oxo-3-phenyl-1,6-dihydropyridin-2-yl)phenyl)cyclobutylcarbamate (0.5 g, 1.159 mmol) in THF (Volume: 25 ml) to give a red suspension followed with the addition of DIPEA (1.0 ml). 2,4-dibromobutanol chloride (0.735 g, 2.78 mmol) in THF (5 ml) was added in drop wise at 0 degree. The resulted mixture was stirred at room temperature for 20 hours. The reaction mixture was transferred to a 250 ml round bottom flask and sodium bicarbonate saturated solution (40 ml) and sodium bicarbonate (1 g) was added. The resulted mixture was heated to reflux for 24 h. The reaction mixture was cooled down to room temperature. The organic phase was separated. The aqueous phase was extracted with ethyl acetate (45 ml). The organic phases were combined and washed with water (30 mlX2), brine (25 ml) then concentrated at reduced pressure. The residue was suspended in DCM (10 ml). The precipitate was collected by filtration and washed with DCM (5 ml) to afford crude product which was purified by biotage column (25 g silicon) to afford tert-butyl 1-(4-(3-(2-hydroxyethyl)-2-oxo-7-phenyl-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutylcarbamate (45 mg) and tert-butyl 1-(4-(7-phenyl-3,3a-dihydro-2H-furo[2,3-e]pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutylcarbamate (0.35 g). 1H NMR (500 MHz, CD3OD): 7.50 (s, 1H), 7.31 (m, 2H), 7.26 (m, 5H), 7.16 (m, 2H), 5.38 (dd, 1H), 4.72 (t, 1H), 4.55 (m, 1H), 2.92 (m, 1H), 2.67 (m, 1H), 2.43-2.47 (m, 4H), 2.07 (m, 1H), 1.85 (m, 1H), 1.23-1.39 (br, 9H). LCMS (Method A): RT=6.89 min, M+H+=498.12. A solution of tert-butyl 1-(4-(7-phenyl-3,3a-dihydro-2H-furo[2,3-e]pyrido[2,3-b][1,4]oxazin-6-yl)phenyl)cyclobutylcarbamate (0.35 g, 0.703 mmol) in DCM (15 ml) and acetic acid (10 ml) was stirred at room temp for 48 h. The reaction mixture was concentrated and portioned between ethyl acetate (40 ml) and water (30 ml). The separated organic phase was washed with water (2×25 ml), brine and concentrated to give product 0.36 g (45 mg). 1H NMR (500 MHz, CD3OD): 7.23-7.31 (m, 8H), 7.16 (m, 2H), 5.05 (dd, 1H), 3.91 (m, 1H), 3.85 (m, 1H), 2.45 (m, 4H), 2.26 (m, 1H), 2.15 (m, 1H), 2.07 (m, 1H), 1.86 (m, 1H), 1.23-1.39 (br, 9H). LCMS (Method A): RT=5.92 min, M+H+=516.04.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09221838B2
Source datasetuspto-grants-2015_12
ORD IDord-caa7c636d2074f5e8db36a57ba18a220
Source noteuspto-grants-2015_12